Susan C. Fagan

11.3k total citations · 1 hit paper
162 papers, 9.0k citations indexed

About

Susan C. Fagan is a scholar working on Epidemiology, Neurology and Molecular Biology. According to data from OpenAlex, Susan C. Fagan has authored 162 papers receiving a total of 9.0k indexed citations (citations by other indexed papers that have themselves been cited), including 81 papers in Epidemiology, 78 papers in Neurology and 33 papers in Molecular Biology. Recurrent topics in Susan C. Fagan's work include Acute Ischemic Stroke Management (80 papers), Neuroinflammation and Neurodegeneration Mechanisms (45 papers) and Neurological Disease Mechanisms and Treatments (34 papers). Susan C. Fagan is often cited by papers focused on Acute Ischemic Stroke Management (80 papers), Neuroinflammation and Neurodegeneration Mechanisms (45 papers) and Neurological Disease Mechanisms and Treatments (34 papers). Susan C. Fagan collaborates with scholars based in United States, Jordan and Saudi Arabia. Susan C. Fagan's co-authors include Adviye Ergul, David C. Hess, Maribeth H. Johnson, Adviye Ergul, Anna Kozak, Abdelrahman Y. Fouda, Ahmed Alhusban, Azza B. El‐Remessy, Wael Eldahshan and Roshini Prakash and has published in prestigious journals such as PLoS ONE, Neurology and Diabetes.

In The Last Decade

Susan C. Fagan

159 papers receiving 8.9k citations

Hit Papers

Guidelines for the Prevention of Stroke in Patients With ... 2010 2026 2015 2020 2010 250 500 750 1000
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Guidelines for the Prevention of Stroke in Patients With Stroke or Transient Ischemic Attack
    2010 1.1k citations Susan C. Fagan et al. Stroke profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Susan C. Fagan United States 52 3.1k 3.0k 2.2k 1.4k 1.4k 162 9.0k
Ángel Chamorro Spain 51 3.9k 1.3× 3.5k 1.2× 1.9k 0.9× 2.1k 1.4× 886 0.6× 173 9.6k
Daniel T. Laskowitz United States 58 2.3k 0.7× 1.5k 0.5× 2.8k 1.3× 3.3k 2.3× 1.5k 1.1× 254 10.2k
Gelin Xu China 45 3.9k 1.3× 1.3k 0.4× 1.4k 0.6× 2.1k 1.5× 843 0.6× 287 8.7k
Roland Veltkamp Germany 53 3.5k 1.1× 3.4k 1.1× 1.5k 0.7× 2.6k 1.8× 2.3k 1.7× 201 9.6k
José Castillo Spain 69 6.0k 2.0× 3.9k 1.3× 3.6k 1.7× 3.7k 2.5× 1.2k 0.9× 355 15.3k
Joaquı́n Serena Spain 49 3.8k 1.2× 1.3k 0.4× 1.4k 0.6× 2.1k 1.4× 1.0k 0.7× 171 7.5k
Justin A. Zivin United States 61 4.9k 1.6× 2.0k 0.7× 2.6k 1.2× 2.4k 1.6× 1.2k 0.9× 174 12.5k
Sung‐Chun Tang Taiwan 43 1.4k 0.4× 1.7k 0.6× 1.6k 0.7× 1.4k 1.0× 643 0.5× 251 6.9k
Exuperio Díez‐Tejedor Spain 41 4.5k 1.4× 1.5k 0.5× 1.3k 0.6× 2.1k 1.5× 641 0.5× 262 8.1k
Masafumi Ihara Japan 57 1.5k 0.5× 4.7k 1.6× 2.1k 1.0× 2.3k 1.6× 713 0.5× 357 11.2k

Countries citing papers authored by Susan C. Fagan

Since Specialization
Citations

This map shows the geographic impact of Susan C. Fagan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Susan C. Fagan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Susan C. Fagan more than expected).

Fields of papers citing papers by Susan C. Fagan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Susan C. Fagan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Susan C. Fagan. The network helps show where Susan C. Fagan may publish in the future.

Co-authorship network of co-authors of Susan C. Fagan

This figure shows the co-authorship network connecting the top 25 collaborators of Susan C. Fagan. A scholar is included among the top collaborators of Susan C. Fagan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Susan C. Fagan. Susan C. Fagan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Li, Weiguo, Yasir Abdul, Raghavendar Chandran, et al.. (2022). Deferoxamine prevents poststroke memory impairment in female diabetic rats: potential links to hemorrhagic transformation and ferroptosis. American Journal of Physiology-Heart and Circulatory Physiology. 324(2). H212–H225. 8 indexed citations
3.
Han, Yohan, Timothy W. Jones, Yin Zhu, et al.. (2021). Overview and Update on Methods for Cargo Loading into Extracellular Vesicles. Processes. 9(2). 356–356. 135 indexed citations
4.
Liu, Fang, Arti Verma, Mir S. Adil, et al.. (2021). Neuroprotective Effects of Fingolimod in a Cellular Model of Optic Neuritis. Cells. 10(11). 2938–2938. 7 indexed citations
5.
Eldahshan, Wael, Mohamed E. Awad, Heba A. Ahmed, et al.. (2021). Stimulation of angiotensin II receptor 2 preserves cognitive function and is associated with an enhanced cerebral vascular density after stroke. Vascular Pharmacology. 141. 106904–106904. 8 indexed citations
6.
Jackson, Ladonya, Guangkuo Dong, Mohammed A. Sayed, et al.. (2019). Delayed Administration of Angiotensin II Type 2 Receptor (AT2R) Agonist Compound 21 Prevents the Development of Post-stroke Cognitive Impairment in Diabetes Through the Modulation of Microglia Polarization. Translational Stroke Research. 11(4). 762–775. 54 indexed citations
7.
8.
Hafez, Sherif, Mohammed Abdelsaid, Susan C. Fagan, & Adviye Ergul. (2017). Peroxynitrite-Induced Tyrosine Nitration Contributes to Matrix Metalloprotease-3 Activation: Relevance to Hyperglycemic Ischemic Brain Injury and Tissue Plasminogen Activator. Neurochemical Research. 43(2). 259–266. 23 indexed citations
9.
10.
Khan, Mohammad Badruzzaman, Md Nasrul Hoda, Kumar Vaibhav, et al.. (2014). Remote Ischemic Postconditioning: Harnessing Endogenous Protection in a Murine Model of Vascular Cognitive Impairment. Translational Stroke Research. 6(1). 69–77. 81 indexed citations
11.
Alhusban, Ahmed, Abdelrahman Y. Fouda, Bindu Pillai, et al.. (2014). Compound 21 is pro-angiogenic in the brain and results in sustained recovery after ischemic stroke. Journal of Hypertension. 33(1). 170–180. 57 indexed citations
12.
Alhusban, Ahmed, Ahmad Al‐Azayzih, Anna Goc, et al.. (2014). Clinically Relevant Doses of Candesartan Inhibit Growth of Prostate Tumor Xenografts In Vivo through Modulation of Tumor Angiogenesis. Journal of Pharmacology and Experimental Therapeutics. 350(3). 635–645. 32 indexed citations
13.
Li, Weiguo, Zhi Qu, Roshini Prakash, et al.. (2013). Comparative analysis of the neurovascular injury and functional outcomes in experimental stroke models in diabetic Goto-Kakizaki rats. Brain Research. 1541. 106–114. 53 indexed citations
14.
Coucha, Maha, Weiguo Li, Maribeth H. Johnson, Susan C. Fagan, & Adviye Ergul. (2013). Protein nitration impairs the myogenic tone of rat middle cerebral arteries in both ischemic and nonischemic hemispheres after ischemic stroke. American Journal of Physiology-Heart and Circulatory Physiology. 305(12). H1726–H1735. 21 indexed citations
15.
Prakash, Roshini, Payaningal R. Somanath, Azza B. El‐Remessy, et al.. (2012). Enhanced Cerebral but Not Peripheral Angiogenesis in the Goto-Kakizaki Model of Type 2 Diabetes Involves VEGF and Peroxynitrite Signaling. Diabetes. 61(6). 1533–1542. 86 indexed citations
16.
Switzer, Jeffrey A., Jennifer L. Waller, Askiel Bruno, et al.. (2012). Clinical Experience With Three-Factor Prothrombin Complex Concentrate to Reverse Warfarin Anticoagulation in Intracranial Hemorrhage. Stroke. 43(9). 2500–2502. 37 indexed citations
17.
Fagan, Susan C.. (2010). Introduction. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 30(7P2). 49S–50S. 4 indexed citations
18.
Fagan, Susan C.. (2010). Drug Repurposing for Drug Development in Stroke. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 30(7P2). 51S–4S. 26 indexed citations
19.
Fagan, Susan C., Anna Kozak, William Hill, et al.. (2006). Hypertension after experimental cerebral ischemia: candesartan provides neurovascular protection. Journal of Hypertension. 24(3). 535–539. 57 indexed citations
20.
Fagan, Susan C., David C. Hess, Sandro Lemos Machado, et al.. (2005). Tactics for Vascular Protection After Acute Ischemic Stroke. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 25(3). 387–395. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ángel Chamorro Breakdown of academic impact, for papers by Daniel T. Laskowitz Breakdown of academic impact, for papers by Gelin Xu Breakdown of academic impact, for papers by Roland Veltkamp Breakdown of academic impact, for papers by José Castillo Breakdown of academic impact, for papers by Joaquı́n Serena Breakdown of academic impact, for papers by Justin A. Zivin Breakdown of academic impact, for papers by Sung‐Chun Tang Breakdown of academic impact, for papers by Exuperio Díez‐Tejedor Breakdown of academic impact, for papers by Masafumi Ihara
Rankless by CCL
2026